Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer.
J Int Med Res
; 48(9): 300060520930440, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32993393
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Proto-Oncogene Proteins B-raf
Limits:
Female
/
Humans
Language:
En
Journal:
J Int Med Res
Year:
2020
Document type:
Article